Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ryan Newman"'
Autor:
Amir Jazaeri, Rahul Sheth, Amanda Nash, Maria Jarvis, Samira Aghlara-Fotovat, Peter Rios, Jose Oberholzer, Omid Veiseh, Guillaume Carmona, Ryan Newman, Jake Schladenhauffen, Suga Subramanian, Nick Luera, Steve Bonk, Ravi Ghanta
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/7a191ec3951d4e9b969695f4bf953e64
Autor:
Guillaume Carmona, Amanda Nash, Ryan Newman, Jake Schladenhauffen, Maria Jarvis, Samira Aghlara-Fotovat, Sudip Mukherjee, Andrea Hernandez, Andrew Hecht, Peter Rios, Shirin Nouraein, Rahul Sheth, Weiyi Peng, Jose Oberholzer, Amir Jazaeri, Omid Veiseh
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33464a9532b0969a30214c3a3e093b27
https://doi.org/10.1136/jitc-2022-sitc2022.1094
https://doi.org/10.1136/jitc-2022-sitc2022.1094
Autor:
Guillaume Carmona, Amanda Nash, Maria Jarvis, Ryan Newman, Jake Schladenhauffen, Samira Aghlara-Fotovat, Andrea Hernandez, Shirin Nouraein, Sudip Mukherjee, Andrew Hecht, Yufei Cui, Jared Lee, Peter Rios, David Zhang, Chunyu Xu, Rahul Sheth Sheth, Weiyi Peng, Jose Oberholzer, Oleg Igoshin, Amir Jazaeri, Omid Veiseh
Publikováno v:
The Journal of Immunology. 208:122.17-122.17
Recombinant IL-2 has been approved for the treatment of melanoma and renal cancer. However, IL-2 therapy is limited by its short half-life in circulation and the associated toxicities that emerge as a result of high systemic exposure. To overcome the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6678df22bd989191a7d9fe0aa8f412a2
https://doi.org/10.4049/jimmunol.208.supp.122.17
https://doi.org/10.4049/jimmunol.208.supp.122.17
Autor:
Ryan Newman, David Peritt, Beauregard Michael, Devyn McKinley Smith, Guillaume Carmona, Christine Carroll, Richard Heidebrecht, Janet Huang, David Moller, Lauren E. Barney, Deya Corzo, Rogerio Vivaldi, Jared A. Sewell
Publikováno v:
Blood. 134:2065-2065
Hemophilia A arises from mutations in the F8 gene, affecting ~ 1/5000 males. Treatment options include frequent intravenous factor and subcutaneous non-factor therapies. While these approaches have been widely used, they have significant limitations,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea0ec643a2d4b09e910089e5e95dae63
https://doi.org/10.1182/blood-2019-127050
https://doi.org/10.1182/blood-2019-127050
Autor:
Ryan Newman
Publikováno v:
Medicine & Science in Sports & Exercise. 37:S205
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73202c83b368497f20392a8dd6dea1c6
https://doi.org/10.1249/00005768-200505001-01069
https://doi.org/10.1249/00005768-200505001-01069